Primary Malignant Liver Neoplasm
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
60
|
4
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
QT interval feature (observable entity)
|
phenotype |
|
Clinical Attribute
|
75
|
226
|
0.100 |
None |
1.000 |
1 |
1
|
2014 |
2014 |
Malignant neoplasm of nasopharynx
|
disease |
Neoplasms; Stomatognathic Diseases; Otorhinolaryngologic Diseases
|
Neoplastic Process
|
136
|
10
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Cancer of Nasopharynx
|
disease |
Neoplasms; Stomatognathic Diseases; Otorhinolaryngologic Diseases
|
Neoplastic Process
|
145
|
12
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
HER2-negative breast cancer
|
disease |
|
Neoplastic Process
|
160
|
18
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Pterygium Of Conjunctiva And Cornea
|
disease |
Eye Diseases
|
Disease or Syndrome
|
169
|
4
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Pterygium of eye
|
disease |
Eye Diseases
|
Disease or Syndrome
|
169
|
4
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Pterygium
|
disease |
Eye Diseases
|
Disease or Syndrome
|
216
|
5
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Androgen-Insensitivity Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
247
|
176
|
0.010 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Lewy Body Disease
|
disease |
Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
255
|
41
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Cervical Intraepithelial Neoplasia
|
disease |
Neoplasms
|
Neoplastic Process
|
398
|
29
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Precancerous Conditions
|
group |
Neoplasms
|
Neoplastic Process
|
471
|
18
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Gallbladder Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
498
|
75
|
0.030 |
None |
1.000 |
3 |
|
2011 |
2012 |
Tumor Initiation
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
533
|
8
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Stomach Neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
820
|
55
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Tumor Angiogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
822
|
5
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Hepatocarcinogenesis
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
855
|
24
|
0.020 |
None |
1.000 |
2 |
|
2011 |
2017 |
Fatty Liver
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
875
|
35
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Cholangiocarcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
877
|
43
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Colonic Neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
947
|
45
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Pancreatic Ductal Adenocarcinoma
|
disease |
Digestive System Diseases; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
970
|
22
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Small cell carcinoma of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
972
|
125
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Malignant transformation
|
phenotype |
|
Neoplastic Process
|
1027
|
20
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Diffuse Large B-Cell Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1043
|
127
|
0.010 |
None |
< 0.001 |
1 |
|
2018 |
2018 |
Colitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
1135
|
15
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |